Breaking News

Rhythm Prescribed drugs Declares New Employment Inducement

BOSTON, Sept. 07, 2022 (GLOBE NEWSWIRE) — Rhythm Prescribed drugs, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical firm centered on remodeling the lives of sufferers and their households dwelling with hyperphagia and extreme weight problems attributable to uncommon melanocortin-4 receptor (MC4R) pathway illnesses, at this time introduced that on September 2, 2022, the Compensation Committee of […]